InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,888.80
(
-0.01%
)
Post# of 43716
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Foxwoods Man

Send PM Follow Ignore
Followers 23
Posts 4995
Boards Moderated 0
Alias Born 11/01/2006

Foxwoods Man

Re: Turney post# 7122

Saturday, 05/30/2015 9:13:05 AM

Saturday, May 30, 2015 9:13:05 AM

Post# of 43716
I saw a similar (or the same) AP article in today's Providence Journal. It mostly addressed already approved immune therapy drugs for a lees common form of lung cancer and also for melanoma.

Re: lung cancer..in the completed study (600 patients) the drug Opdivo increased the life expectancy from 9 months to 12 months. Tumors shrank in 20% of Opdivo patients vs. 12% without the drug.

The article also mentioned that "immune therapies can play a broader role in more common cancers including lung, liver, colon and head and neck"
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CVM News
More CVM News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!